# EDGAR Filing Document

**Accession Number:** 0001284967
**File Stem:** 0001127602-23-002326
**Filing Date:** 2023-1
**Character Count:** 8560
**Document Hash:** 4a05df9477f5da35a22adc384911af95
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-002326.hdr.sgml**: 20230126

**ACCESSION NUMBER**: 0001127602-23-002326

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230124

**FILED AS OF DATE**: 20230126

**DATE AS OF CHANGE**: 20230126

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** MAIN SUE
- **CENTRAL INDEX KEY:** 0001284967

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-211719
- **FILM NUMBER:** 23558721

**MAIL ADDRESS:**
- **STREET 1:** TELEDYNE TECHNOLOGIES INCORPORATED
- **STREET 2:** 1049 CAMINO DOS RIOS
- **CITY:** THOUSAND OAKS
- **STATE:** CA
- **ZIP:** 91360
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ASHLAND INC.
- **CENTRAL INDEX KEY:** 0001674862
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-CHEMICALS & ALLIED PRODUCTS [5160]
- **IRS NUMBER:** 812587835
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 8145 BLAZER DRIVE
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19808
- **BUSINESS PHONE:** 304-995-3000

**MAIL ADDRESS:**
- **STREET 1:** 8145 BLAZER DRIVE
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19808

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ASHLAND GLOBAL HOLDINGS INC
- **DATE OF NAME CHANGE:** 20160517

## Ex-24

```

POWER OF ATTORNEY

The undersigned hereby appoints Babatunde Awodiran his or her true and
lawful attorney-in-fact to:

(1) apply for and obtain on behalf of the undersigned, in the undersigneds
capacity as a director and/or stockholder of Ashland Global Holdings Inc.,
the necessary access codes to file Forms 3, 4, 5 and 144, pursuant to
Section 16(a) of the Securities Exchange Act of 1934 and Rule 144 of the
Securities Act of 1933, respectively, electronically via the EDGAR system
pursuant to Regulation S-T and the rules thereunder, and

(2) act in a filing agent capacity to perform any and all acts for and on
behalf of the undersigned, in the undersigned?s capacity as a director and/or
stockholder of Ashland Global Holdings Inc., which may be necessary to
complete the filing of any such Form 3, 4, 5 and 144 with the U.S. Securities
and Exchange Commission and any other authority in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder.

The undersigned hereby grants to attorney-in-fact the full power and
authority, for me and on my behalf, to perform all acts necessary and proper
to be done in the exercise of the rights and powers hereby granted.

The undersigned acknowledges that the foregoing individual is acting under
this Power of Attorney at the request of the undersigned, and is not assuming
any of the undersigned?s responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933.

The attorney-in-fact shall be authorized to act under this Power of Attorney
only so long as such attorney-in-fact is an officer of Ashland Global Holdings
Inc., or until such time as this Power of Attorney has been revoked, annulled
or set aside.

IN WITNESS WHEREOF, the undersigned has executed this Power of
Attorney as of this 8th day of June, 2021.

/s/ Susan Main

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>MAIN SUE<br><sub>(Last) (First) (Middle)</sub><br>8145 BLAZER DRIVE<br><sub>(Street)</sub><br>WILMINGTON, DE 19808<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ASHLAND INC. [ ASH ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-24 |  | A |  | 1365 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 1365 | $109.85 | 9315<sup>(3)</sup> | D |  |

---

### Footnotes:

(1) Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.

(2) Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and deferred at the election of the reporting person under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022 until retirement from service as a director. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock.

(3) Balance includes 27 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 25 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 26 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 23 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022.

**Signature:** /s/ Babatunde Awodiran, Attorney-in-Fact  
**Date:** 2023-01-26

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**